Cardinal Health 2008 Annual Report Download - page 30

Download and view the complete annual report

Please find page 30 of the 2008 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

All Other. This reportable segment will comprise Medicine Shoppe and the pharmacy services, Tecomet and
MedSystems businesses. The Company entered into a definitive agreement to sell the Tecomet business to
Charlesbank Capital Partners and Tecomet management on July 22, 2008.
As noted above, the Company has publicly announced that its management is actively exploring a potential
separation of the Company’s new Healthcare Supply Chain Services and Clinical and Medical Products
reportable segments. The separation being explored could involve a tax-free spin-off of all or a portion of the
businesses comprising the Clinical and Medical Products reportable segment as a separate, publicly traded
company.
Acquisitions and Divestitures
From July 1, 2003 to June 30, 2008, the Company completed the acquisitions described below.
Consideration Paid
Date (1) Company Location Line of Business Cash
Stock
Options
Converted (2)
(Amounts in millions)
December 16, 2003 The Intercare Group, plc United Kingdom Contract services
manufacturer and
distributor for
pharmaceutical
companies
$ 570(3) —
June 28, 2004 ALARIS Medical
Systems, Inc.
San Diego, California Intravenous medication
safety products and
services
$2,080(4) 0.6
June 21, 2007 VIASYS Healthcare
Inc.
Conshohocken,
Pennsylvania
Respiratory, neurology,
medical disposable and
orthopedic products
$1,526(5) 0.1
May 12, 2008 Enturia Inc. Leawood,
Kansas
Infection prevention
products
$ 490(6) —
(1) Represents the date the Company became the majority shareholder.
(2) As a result of the acquisition, the outstanding stock options of the acquired company were converted into options to
purchase the Company’s Common Shares. This column represents the number of the Company’s Common Shares
subject to such converted stock options immediately following conversion.
(3) Includes the assumption of approximately $150 million in debt.
(4) Includes the assumption of approximately $358 million in debt.
(5) Includes the assumption of approximately $54 million in debt; also includes approximately $88 million of shares
purchased under equity compensation plans in July 2007.
(6) Includes the assumption of approximately $5 million in debt.
The Company also has completed a number of other smaller acquisitions (asset purchases, stock purchases
and mergers) during the last five fiscal years, including the following: Medicap and Snowden Pencer Holdings,
Inc. during fiscal 2004; Geodax Technology, Inc. during fiscal 2005; and ParMed Pharmaceutical, Inc.
(“ParMed”) and Denver Biomedical, Inc. (“Denver Biomedical”) during fiscal 2006. The Company also acquired
the wholesale pharmaceutical, health and beauty and related drugstore products distribution business of The
F. Dohmen Co. and certain of its subsidiaries (“Dohmen”) and the remaining shares of Source Medical
Corporation (“Source Medical”), its Canadian joint venture, during fiscal 2006. The Company acquired
MedMined, Inc. (“MedMined”), Care Fusion Incorporated (“Care Fusion”) and SpecialtyScripts, LLC
(“SpecialtyScripts”) during fiscal 2007. In addition to the acquisitions described above, the Company completed
the acquisition of Borschow Hospital & Medical Supplies, Inc., a distributor of pharmaceutical and medical
products in Puerto Rico, on August 1, 2008.
6